These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 19661076)

  • 1. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
    Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
    Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
    Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T; Vairaktaris E; Nkenke E; Schlegel KA; Neukam FW; Ries J
    Anticancer Res; 2009 Jan; 29(1):291-7. PubMed ID: 19331164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
    J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 in patients with renal cell carcinoma].
    Hioki T; Sugimura Y
    Hinyokika Kiyo; 1999 Aug; 45(8):577-81. PubMed ID: 10500966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
    Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
    Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
    Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Loening SA; Jung K
    Cancer Lett; 2008 Sep; 269(1):85-92. PubMed ID: 18504068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
    Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
    J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcinoma.
    Klein A; Fishman A; Zemer R; Zimlichman S; Altaras MM
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):352-5. PubMed ID: 10985893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.